VERAXA Biotech AG (VRXA)

NASDAQ: VRXA · Real-Time Price · USD
22.00
-2.79 (-11.25%)
Jun 12, 2026, 10:56 AM EDT - Market open
Market Cap556.60M
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out 25.30M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,716
Open20.00
Previous Close24.79
Day's Range17.12 - 21.96
52-Week Range8.40 - 27.36
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About VRXA

VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation.... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country Germany
Stock Exchange NASDAQ
Ticker Symbol VRXA
Full Company Profile